Selective Therapeutic Potential of a H2O2-Inducible DNA Interstrand Cross-linker in Anaplastic Thyroid Carcinoma
Endocrinology · 2025
DOI: 10.1210/endocr/bqaf029 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrinology, 2025. Verfasst von Chenghui Lu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Tianjin Medical University General Hospital, Tianjin 300052, P. R. China. Hauptthemen laut MEDLINE: DNA, Neoplasm, Hydrogen Peroxide, Thyroid Carcinoma, Anaplastic, Thyroid Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Tianjin Science and Technology Committee.
Abstract (Originalsprache)
We aimed to investigate hydrogen peroxide–inducible DNA interstrand cross-link (HP-ICL) as a targeted therapy for anaplastic thyroid cancer (ATC) due to its higher H2O2 content than normal cells. In vitro analysis included fluorescence microscopy for H2O2 levels and exposure of ATC cells to various HP-ICL concentrations followed by assessment of cell viability, apoptosis, cell cycle, and DNA damage using methyl thiazolyl tetrazolium (MTT), flow cytometry, and a γH2AX assay. Protein levels related to apoptosis and the phosphatidylinositol-3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/AKT/mTOR) pathway were measured by Western blotting. An ATC xenograft mouse model was used to evaluate the HP-ICL's in vivo effects. ATC cells had higher H2O2 levels than normal thyroid cells. HP-ICL treatment caused a dose-dependent decrease in cell viability and an increase in apoptosis, with a slight G2/M phase arrest. A 30 µM HP-ICL treatment doubled γH2AX foci. Bcl-2 levels decreased, while Bax, cleaved-Caspase 3, and PARP increased in a dose-dependent manner. It also inhibited p-PI3K, p-AKT, and p-mTOR. In vivo, the HP-ICL significantly inhibited tumor growth while maintaining body weight and without causing organ damage or altering thyroid hormone levels. Additionally, tumor sections exhibited increased TUNEL staining, decreased Ki67 expression, and reduced levels of p-PI3K, p-AKT, and p-mTOR. The HP-ICL significantly inhibited ATC both in vitro and in vivo, suggesting its potential as an effective therapy for ATC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Tianjin Medical University General Hospital, Tianjin 300052, P. R. China.
- Department of Nuclear Medicine, The Affiliated Hospital of Qingdao University, Qingdao 266003, P. R. China.
- Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics School of Pharmacy, Tianjin Medical University, Tianjin 300070, P. R. China.
ORCID-Profile: Xufu Wang, Wei Zheng, Huabing Sun, Zhaowei Meng
Förderung
- National Natural Science Foundation of China
- Tianjin Science and Technology Committee
Zitieren
APA
Lu, C., Yu, D., Wang, X., Li, J., Zhang, Y., Wang, C., Jia, Q., Tan, J., Zheng, W., Sun, H., & Meng, Z. (2025). Selective Therapeutic Potential of a H2O2-Inducible DNA Interstrand Cross-linker in Anaplastic Thyroid Carcinoma. Endocrinology. https://doi.org/10.1210/endocr/bqaf029
Vancouver
Lu C, Yu D, Wang X, Li J, Zhang Y, Wang C, et al. Selective Therapeutic Potential of a H2O2-Inducible DNA Interstrand Cross-linker in Anaplastic Thyroid Carcinoma. Endocrinology. 2025. doi:10.1210/endocr/bqaf029
BibTeX
@article{Lu2025,
author = {Lu, Chenghui and Yu, Dehao and Wang, Xufu and Li, Jiao and Zhang, Yingying and Wang, Congcong and Jia, Qiang and Tan, Jian and Zheng, Wei and Sun, Huabing and Meng, Zhaowei},
title = {Selective Therapeutic Potential of a H2O2-Inducible DNA Interstrand Cross-linker in Anaplastic Thyroid Carcinoma},
journal = {Endocrinology},
year = {2025},
doi = {10.1210/endocr/bqaf029}
}
EUVIMED